Dexamethasone has been reported to decrease the levels of the plasma membrane-associated glucose transporter GLUT1 [22], and targeting the sodium–glucose cotransporter 2 (SGLT2) ameliorates glucocorticoid-induced osteoporosis [24]. Here, SLC2A1 is linked to osteoporosis.